Ozempic 8 mg/3 mL (2.68 mg/mL) prefilled pen Images
Generic Name: semaglutide
This medication has been identified as Ozempic 8 mg/3 mL (2.68 mg/mL) prefilled pen. It is supplied by Novo Nordisk.
Ozempic is used in the treatment of Cardiovascular Risk Reduction; Diabetes, Type 2 and belongs to the drug class incretin mimetics. Ozempic 8 mg/3 mL (2.68 mg/mL) prefilled pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Ozempic
- Generic Name
- semaglutide
- Strength
- 8 mg/3 mL (2.68 mg/mL) prefilled pen
- Availability
- Prescription only
- Drug Class
- Incretin mimetics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novo Nordisk
- National Drug Code (NDC)
- 00169-4772
More about Ozempic (semaglutide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,123)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: incretin mimetics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.